INTERVIEW
summary
AI and ML are now mature, with many vendors offering standard tools; pharmaceutical product development typically takes months if not years, so applying AI to reduce cycle time and to extract insights from vast clinical and production data delivers clear value. Regulatory audits require fully digital, audit‑ready processes, driving investment in storage and retrieval pipelines and in automated, non-paper workflows tied to vendor platforms and operational monitoring stacks.
AI-written summary · about
related talks
23mAI in the Life Science Sector
08mEngineering the Future of Pharma: AI-Driven Drug Discovery
11mFaster to the Patient: How AI Is Revolutionizing the Pharmaceutical Industry
30mAI in Drug Discovery
19mThe future of AI in powering clinical trial innovation
23mAI Here & Now
29mScaling AI - Creating value with the application of AI
17mAI Innovation in Health